Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Paclitaxel - Angiotech

Drug Profile

Paclitaxel - Angiotech

Alternative Names: Cremophor EL-free paclitaxel - Angiotech; Eluvia; Formula PTX; Innova; Micellar paclitaxel; Paxceed; TAXUS Element; TAXUS Express2; TAXUS Liberte; TAXUS Petal; Vascular Wrap; Zilver PTX

Latest Information Update: 26 Sep 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Angiotech Pharmaceuticals
  • Developer Angiotech Pharmaceuticals; Boston Scientific Corporation; Broncus Technologies; Cook Medical
  • Class Antineoplastics; Diterpenes; Paclitaxels; Small molecules; Taxanes
  • Mechanism of Action Angiogenesis inhibitors; Immunosuppressants; Proto-oncogene protein c-bcl-2 inhibitors; Tubulin inhibitors; Tubulin polymerisation promoters
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Coronary artery restenosis; Myocardial infarction; Vascular restenosis
  • No development reported Emphysema
  • Discontinued Alzheimer's disease; Cancer; Multiple sclerosis; Oesophageal cancer; Post-surgical adhesions; Psoriasis; Rheumatoid arthritis

Most Recent Events

  • 24 Sep 2018 The US FDA approves a Premarket Approval application of Eluvia™ Drug-Eluting Vascular Stent System for Peripheral artery disorders
  • 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Vascular-restenosis in Europe (Intra-arterial)
  • 31 Mar 2017 Cook Medical completes a clinical trial in Vascular restenosis in China (NCT02171962)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top